Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents

Although yeast bloodstream infections (BSIs) are increasingly being reported in patients with hematological malignancies undergoing antifungal therapy, clinical information regarding breakthrough infections is scarce. The aim of this study was to determine the risk factors for and clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Si-Hyun, Choi, Jae-Ki, Cho, Sung-Yeon, Lee, Hyo-Jin, Park, Sun Hee, Choi, Su-Mi, Lee, Dong-Gun, Choi, Jung-Hyun, Yoo, Jin-Hong, Lee, Jong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896439/
https://www.ncbi.nlm.nih.gov/pubmed/28525644
http://dx.doi.org/10.1093/mmy/myx038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896439/
https://www.ncbi.nlm.nih.gov/pubmed/28525644
http://dx.doi.org/10.1093/mmy/myx038

Ejemplares similares